On May 6, 2024, Novo Nordisk started a share repurchase program to acquire up to DKK 2.2 billion in B shares from May 7 to August 5, 2024, as part of a larger DKK 20 billion plan that began on February 6, 2024. By May 16, 2024, they had repurchased 8,976,250 shares at an average price of DKK 862.94.